Finance

Lists
Q3 2026 earnings • in 1 day
See details
OPK:NASDAQ
OPKO Health Inc
$1.80
+4.36%
(+0.075) 1D
Nov 3, 9:54:44 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OPK...
Open
$1.75
High
$1.80
Low
$1.74
Mkt. cap
1.34B
Avg. vol.
4.38M
Volume
258.03K
52-wk high
$1.80
52-wk low
$0.98
EPS
-$0.10
Beta
1.52
Shares outstanding
746.33M
No. of employees
2K
Open
$1.75
High
$1.80
Low
$1.74
Mkt. cap
1.34B
Avg. vol.
4.38M
Volume
258.03K
52-wk high
$1.80
52-wk low
$0.98
EPS
-$0.10
Beta
1.52
Shares outstanding
746.33M
No. of employees
2K
News stories
From web sources and news partners
About OPKO Health Inc
CEO-
Employees2.28K
Founded1991
HeadquartersMiami, Florida, United States
SectorHealth care provider
Websiteopko.com
Analyst ratings
Based on 3 analysts giving stock ratings to OPK in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for OPK in the last 3 months.
Highest
Current $1.80
$4.00 (+122.84%)
Average
$3.08 (+71.59%)
Lowest
$2.25 (+25.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
$3.00
+67.1%
10/27/2026
Michael Petusky
Barrington
Buy
Upgraded
$2.25
+25.3%
10/16/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
$4.00
+122.8%
10/16/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
$3.00
+67.1%
02/27/2026
Next call in 30:31:25
Wed, Nov 4, 4:30 PM
Fiscal period
Q3 2026
- / -$0.06
Revenue / Est. (USD)
- / 136.62M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
151.67M
148.45M
124.20M
163.58M
Cost of goods sold
131.85M
117.20M
107.64M
116.73M
Cost of revenue
131.85M
117.20M
107.64M
116.73M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53.80M
55.22M
48.61M
52.92M
Operating expense
73.34M
74.27M
67.57M
71.89M
Total operating expenses
205.19M
191.47M
175.21M
188.62M
Operating income
-53.52M
-43.02M
-51.02M
-25.04M
Other non operating income
610.00K
-354.00K
139.00K
1.63M
EBT including unusual items
41.43M
-46.92M
-60.96M
-13.40M
EBT excluding unusual items
-60.15M
-51.38M
-57.31M
-31.47M
Income tax expense
19.80M
-15.66M
-6.11M
-4.98M
Effective tax rate
47.79%
33.38%
10.02%
37.19%
Other operating expenses
-
-
-
-
Net income
21.63M
-31.26M
-54.85M
-8.42M
Net profit margin
14.26%
-21.06%
-44.16%
-5.14%
Earnings per share
-
-0.04
-
-0.03
Interest and investment income
3.02M
3.82M
3.01M
3.22M
Interest expense
-11.36M
-11.31M
-10.94M
-11.38M
Net interest expenses
-8.34M
-7.49M
-7.93M
-8.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
-30.78M
-20.64M
-28.82M
-2.63M
Gain or loss from assets sale
-101.56M
601.00K
-34.00K
-17.92M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps